Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Guila Delouya, MD"'
Autor:
Leah Taussky, Sabrina Harmouch, MD, BSc, Guila Delouya, MD, MSc, Carole Lambert, MD, MSc, Jean-Paul Bahary, MD, MSc, Louise Lambert, MD, Laura Masucci, MD, Normand Blais, MD, An Tang, MD, MSc, Daniel Liberman, MD, Kevin C. Zorn, MD, Daniel Taussky, MD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 3, Pp 313-317 (2020)
Purpose: The progress of women in academic medicine appears to be curtailed. We evaluated gender differences in academia for residents in radiation oncology compared with 2 of its related specialties, radiology and medical oncology, across Canada. Me
Externí odkaz:
https://doaj.org/article/fc86822a199b4deaa0ec664c6549de64
Autor:
Lara Hathout, MD, FRCPC, Omar Mahmoud, MD, PhD, Yaqun Wang, PhD, Irina Vergalasova, PhD, Maroie Barkati, MD, FRCPC, Philippe Després, PhD, André-Guy Martin, MD, MSc, FRCPC, William Foster, MD, FRCPC, Frédéric Lacroix, PhD, Guila Delouya, MD, MSc, FRCPC, Daniel Taussky, MD, FRCPC, Gerard Morton, MD, FRCPC, Eric Vigneault, MD, MSc, FRCPC
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 4, Pp 631-640 (2019)
Purpose: To compare health-related quality of life (HRQOL) of high-dose-rate brachytherapy (HDRB) versus low dose-rate brachytherapy (LDRB) for localized prostate cancer in a multi-institutional phase 2 randomized trial. Methods and Materials: Men wi
Externí odkaz:
https://doaj.org/article/05bb84c95123416c9cb0633640430fe4
Autor:
William F. Regine, MD, Kathryn Winter, MS, Ross A. Abrams, MD, Howard Safran, MD, Ivan L. Kessel, MD, Yuhchyau Chen, MD, PhD, James A. Fugazzi, MD, Eric D. Donnelly, MD, Thomas A. DiPetrillo, MD, Samir Narayan, MD, John P. Plastaras, MD, Rakesh Gaur, MD, Guila Delouya, MD, John H. Suh, MD, Joshua E. Meyer, MD, Michael G. Haddock, MD, Mukund S. Didolkar, MD, Gilbert D.A. Padula, MD, David Johnson, MD, John P. Hoffman, MD, Christopher H. Crane, MD
Publikováno v:
Advances in Radiation Oncology, Vol 3, Iss 2, Pp 154-162 (2018)
Purpose: NRG Oncology RTOG 9704 was the first adjuvant trial to validate the prognostic value of postresection CA19-9 levels for survival in patients with pancreatic carcinoma. The data resulting from this study also provide information about predict
Externí odkaz:
https://doaj.org/article/7807a6dd9b14475d9809d5afcb59b0df